Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Response of EMT-6 Tumors to Single Fractions of X Rays and Cyclotron Neutrons: Evaluation and Comparison of Multiple Endpoints

Janet S. Rasey, Rita E. Carpenter and Norma J. Nelson
Radiation Research
Vol. 71, No. 2 (Aug., 1977), pp. 430-446
DOI: 10.2307/3574685
Stable URL: http://www.jstor.org/stable/3574685
Page Count: 17
  • Read Online (Free)
  • Download ($10.00)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Response of EMT-6 Tumors to Single Fractions of X Rays and Cyclotron Neutrons: Evaluation and Comparison of Multiple Endpoints
Preview not available

Abstract

EMT-6 cells growing in vitro or as solid tumors were treated with single fractions of 250-kVp X rays or cyclotron neutrons (21.5-MeV ${\rm d}^{+}$ on Be). The neutron RBEs for cell survival in vitro are 1.5 to 1.6 in the exponential region, less than the RBEs of 1.8 to 2.5 for mitotic delay. The relatively greater delay produced by neutrons can influence cell progression and also response of survivors to subsequent doses of radiation in a manner different from that occurring after an X-ray dose isoeffective for cell killing. The in vivo endpoints of tumor response examined were clonogenic cell survival, local tumor control, and growth delay. RBEs for growth delay range from 2.3 to 2.4, but are not statistically significantly different from RBEs for cure or clonogenic cell survival. The large neutron RBE of 3.0 for clonogenic cell survival at intermediate as well as high doses is based on apparent tumor hypoxia caused by anesthesia. The low neutron RBE of 1.7 for local control is due to immunosuppression caused by leakage and scatter neutron radiation to the animal's body during localized treatment of the tumor; leakage and scatter whole-body photon exposure is negligible. Low-dose whole-body neutron irradiation reduces the TD50 in mice preimmunized with heavily irradiated tumor cells. This is consistent with the above explanation of the lowered RBE for local tumor control.

Page Thumbnails

  • Thumbnail: Page 
430
    430
  • Thumbnail: Page 
431
    431
  • Thumbnail: Page 
432
    432
  • Thumbnail: Page 
433
    433
  • Thumbnail: Page 
434
    434
  • Thumbnail: Page 
435
    435
  • Thumbnail: Page 
436
    436
  • Thumbnail: Page 
437
    437
  • Thumbnail: Page 
438
    438
  • Thumbnail: Page 
439
    439
  • Thumbnail: Page 
440
    440
  • Thumbnail: Page 
441
    441
  • Thumbnail: Page 
442
    442
  • Thumbnail: Page 
443
    443
  • Thumbnail: Page 
444
    444
  • Thumbnail: Page 
445
    445
  • Thumbnail: Page 
446
    446